No results for ‘’
Indrayani Biotech Ltd
₹10.85
(1.36%)
Wed, 24 Jun 2026, 08:54 pm
Consumer Services
Restaurants
24.5KIndrayani Biotech Price to Sales Ratio (P/S)
| Particulars | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.77 | 0 | 23.51 | 16.21 | 21.48 | 0 |
| Price to book ratio | 0 | 0 | 4.18 | 4.20 | 4.31 | 4.40 | 4.53 | 0.62 | 0.57 | 0 | 0 | 0.10 | 1.10 | 4.32 | 3.51 | 3.33 | 0.90 |
| Price to sales ratio | 3.76 | 8.60 | 0.38 | 0.25 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.06 | 1.05 | 1.70 | 1.19 | 1.35 | 0.50 |
| Price to cash flow ratio | 0 | 0 | 17.02 | 10.89 | 223.97 | 0 | 0 | 0 | 0 | 0 | 0 | 0.63 | 0 | 0 | 0 | 0 | 0 |
| Enterprise value | 0.86Cr | 1.71Cr | 16.76Cr | 15.41Cr | 14.84Cr | 14.9Cr | 14.99Cr | 2.31Cr | 2.19Cr | 2.69Cr | 3.19Cr | 15.38Cr | 36.95Cr | 122Cr | 255Cr | 345Cr | 229Cr |
| Enterprise value to EBITDA ratio | 0 | 0 | 18.66 | 20.01 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5.53 | 0 | 18 | 14.75 | 14.58 | 35.51 |
| Debt to equity ratio | 0 | 0 | 0.62 | 0.53 | 0.04 | 0.04 | 0.08 | 0.13 | 0.16 | 0 | 0 | 0.45 | 0.79 | 0.78 | 1.30 | 1.67 | 1.89 |
| Return on equity % | 0 | 0 | -3.12 | -1.84 | -0.18 | -2.06 | -3.06 | -4.05 | -7.84 | -10.24 | 0 | 5.35 | -117.94 | 20.23 | 30.11 | 17.04 | -8.74 |
Indrayani Biotech Ltd Price to Sales Ratio
The Indrayani Biotech Ltd Price to Sales Ratio is a key financial metric used by investors to evaluate Indrayani Biotech Ltd's valuation, profitability, and overall financial performance. Tracking the Indrayani Biotech Ltd Price to Sales Ratio helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
Indrayani Biotech Ltd (NSE: , BSE: 526445) is currently trading at ₹10.85, with a market capitalization of ₹48.31Cr. As a leading company in the Consumer services sector and Restaurants industry, monitoring the Indrayani Biotech Ltd Price to Sales Ratio is essential for fundamental analysis.
Indrayani Biotech Ltd Price to Sales Ratio Current Value
The current Indrayani Biotech Ltd Price to Sales Ratio stands at 0.50.
The Indrayani Biotech Ltd Price to Sales Ratio has declined compared to earlier levels, suggesting improved fundamentals or more attractive valuation.
Indrayani Biotech Ltd Price to Sales Ratio Historical Trend
The Indrayani Biotech Ltd Price to Sales Ratio has shown the following historical trend:
- 2024: 0.50
- 2023: 1.35
- 2022: 1.19
- 2021: 1.70
- 2020: 1.05
The decline in Indrayani Biotech Ltd Price to Sales Ratio indicates improving financial efficiency or better earnings growth.
What Indrayani Biotech Ltd Price to Sales Ratio Indicates for Investors
The Indrayani Biotech Ltd Price to Sales Ratio plays a crucial role in understanding the company's financial health and valuation.
The P/S ratio helps evaluate valuation relative to company revenue.
Indrayani Biotech Ltd Price to Sales Ratio Analysis Summary
The Indrayani Biotech Ltd Price to Sales Ratio remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Indrayani Biotech Ltd Price to Sales Ratio should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of Indrayani Biotech Ltd Price to Sales Ratio helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.